Drug Summary


These are not results of clinical trials. This table summarizes preliminary responses from an internet survey not supported by or affiliated with UCLA and not supervised or verified by an MD. These results should not be used for anything more than a resource for discussion of treatments with your consulting physician.

DRUG TOTAL TAKEN EFFECTIVE SLIGHTLY EFFECTIVE NO EFFECT NO COMMENT BAD RXN TERM>37 <=37 LOSS>=12 ABORT
                     
B6 26 1 1 11 13   15 6 3 2
UNISOM 8 2 1 3 2   5 1 2 0
MEREZINE 5 2 0 2 1 2 4 1 0 0
ANTIVERT 1 0 0 1 0   1 0 0 0
DRAMAMINE 7 0 0 3 4   7 0 0 0
BENADRYL 14 0 1 5 8   6 3 3 2
REGLAN 15 2 5 7 1 6 9 4 1 0
SCOPOLAMINE 3 0 0 3 0   1 0 1 0
PHENERGAN 55 6 4 30 15 13 32 11 7 3
COMPAZINE 40 2 2 27 9 13 22 9 4 3
THORAZINE 6 1 0 3 2 2 6 0 0 0
TIGAN 21 0 2 14 5 2 13 2 5 0
PROPULSID 2 0 0 0 2   1 1 0 0
INAPSINE 1 0 0 1 0 1 1 0 0 0
ZOFRAN 21 9 4 4 4 1 8 4 5 1
STEROIDS 5 5 0 0 0   3 1 0 1
ATARAX 0 0 0 0 0   0 0 0 0
ZANTAC 8 0 1 4 3   7 0 0 0
DICLECTIN 1 1 0 0 0   1 0 0 0
MARIJUANA 4 2 0 1 1   2 0 0 1
ANTIDEPRESS 3 0 0 0 3   1 1 1 0
BENDECTIN 1 1 0 0 0   1 0 0 0
OTHER 5           2 2 1 0



"Total taken" is the total number of respondents who reported using the drug.
"Effective", "Slightly effective", and "No effect" are the number of cases where the drug was reported as effective, slightly effective, and ineffective, respectively. These 3 columns plus "No comment" add up to "Total taken".
"Bad Rxn" is the number of cases where the drug was reported to have an adverse side effect.
"Term > 37" and "<= 37" are the number of cases where the baby was carried to term after greater than 37 weeks of pregnancy or less than or equal to 37 weeks, respectively.
"Loss >=12" is the number of cases of fetal loss after at least 12 weeks of pregnancy.
"Abort" is the number of cases ending in abortion.


Last Updated on 2/20/01
By Statistics Administration